Introduction
Fusarium moniliforme is a significant plant pathogen that primarily infects corn but can also infect rice and wheat [reviewed in (1) (2) (3) (4) (5) (6) (7) ]. The fungus is widespread and produces a variety of mycotoxins; the major class is called fumonisin. Several subtypes of fumonisin have been identified (A, B, or C), and all these compounds resemble sphingolipids [reviewed in (8) (9) (10) ]. FB 1 inhibits sphingosine N-acetyltransferase (ceramide synthase) and thus blocks sphingolipid biosynthesis. FB 1 and FB 2 are of toxicologic significance because they are present at high concentrations on diseased plants and are frequently detected on healthy corn plants (11) .
Ingestion of moldy corn infected by F. moniliforme or closely related fungi is linked to a higher incidence of primary liver cancer (12) and esophageal cancer in regions of South Africa and China (13) . In rats fed a diet containing 50 mg/kg FB 1 , primary hepatocellular carcinoma occurred in two thirds of the animals (14) (15) (16) . FB 1 is also a potent tumor promoter in rat liver after initiation with diethylnitrosamine (17) . Cancer-promoting activity has occurred at levels that did not induce liver or kidney toxicity and, furthermore, did not initiate cancer.
Culture material from F. moniliforme containing FB 1 induces equine leukoencephalomalacia and nephrotoxicity (18) . Purified preparations of FB 1 are also hepatotoxic (19) , cause porcine pulmonary edema (20) , and are nephrotoxic to several animal species (21) (22) (23) . In vivo studies have demonstrated that FB 1 induces apoptosis in rat kidney and liver (24) (25) (26) . FB 1 also induces apoptosis of several different mammalian cell types (26) (27) (28) (29) , demonstrating that treatment can lead directly to apoptosis. A previous study demonstrated that neoplastic African green monkey kidney cells (COS-7) are resistant to the apoptotic and antiproliferative effects of FB 1 compared to their normal counterparts, African green monkey kidney cells (CV-1) (29, 30) . Murine or human leukemia cells do not undergo apoptosis when treated with FB 1 (30, 31) . We have also found that other cell lines derived from human tumors are resistant to the effects of FB 1 (data not shown). Taken together, these studies suggested that transformed cells, in general, are resistant to the effects of FB 1 . Because the ability of cells to escape apoptosis plays a critical role in the development of cancer, the ability of FB 1 to induce apoptosis may select for cells resistant to apoptosis. It is hypothesized that these cells would have altered growth capabilities.
The goal of this study was to characterize FB 1 -induced apoptosis. A previous study demonstrated that cyclin-dependent kinase (cdk) activity increased slightly after 3 hr of FB 1 treatment but then declined (30) . This is significant because cdk activity transiently increases during the early stages of apoptosis (32) . Further studies confirmed that cdk2 activity transiently increased after FB 1 treatment. Several pathways have been identified that result in programmed cell death or apoptosis [reviewed in (33) ]. A quantitative assay for apoptosis was used to identify specific genes that interfere with FB 1 -induced apoptosis. This assay indicated that a baculovirus gene (CpIAP) inhibited FB 1 -induced apoptosis. Because CpIAP inhibits tumor necrosis factor (TNF)-induced apoptosis, we further examined other factors involved in TNF signal transduction pathways. A caspase involved with TNF-induced apoptosis (caspase 8) was cleaved and activated within 2 hr after treatment. In contrast, nuclear factor kappa-B (NF-κB), a transcription factor downstream of the TNF receptor (TNFR) but independent of the apoptotic pathway was not activated following FB 1 treatment. Taken together, this study suggested that the TNF signal transduction pathway (directly or indirectly) plays a role in FB 1 -induced apoptosis. Further studies will be necessary to prove that the TNFR or downstream factors are directly affected by FB 1 .
Materials and Methods

Cells Lines and Media
CV-1 cells were split at 1:5 ratio every 5 days. Mouse embryo fibroblasts (MEF) with a disrupted p53 gene (p53 -/-) were obtained from E. Lee (University of Texas Southwestern Medical Center, San Antonio, Texas, USA) and T. Jacks (Massachusetts Institute of Technology, Cambridge, MA, USA). Normal MEF were prepared from Balb/C mice. MEF were split 5-7 times and then discarded. Cells were grown in Earle's modified Eagle's medium supplemented with 5% fetal bovine serum (FBS), penicillin (10 U/mL), and streptomycin (100 µg/mL) and were plated at a density of 5 × 10 5 cells/100-mm plastic dish.
Fumonisins are mycotoxins produced by Fusarium moniliforme, a prevalent fungus that infects corn and other cereal grains. Fumonisin B 1 (FB 1 ) is the most common mycotoxin produced by F. moniliforme, suggesting it has toxicologic significance. The structure of FB 1 resembles sphingoid bases, and it inhibits ceramide synthase. Because sphingoid bases regulate cell growth, differentiation, transformation, and apoptosis, it is not surprising to find that FB 1 
Bluo-gal Co-Transfection and Analysis of Cell Death
Cells were plated at a density of 2 × 10 5 /well in 6-well plastic plates (35 mm/well) 12-16 hr prior to the transfection. Cells were then transfected with plasmid DNA containing the β-galactosidase gene [cytomegalovirus (CMV-β-gal)] by the calcium phosphate method (34) . Samples were co-transfected with a mammalian expression plasmid that influences cell growth or apoptosis. A description of these plasmids is presented below. For each 35-mm well, 250 µL calcium phosphate solution (125 mM CaCl 2 ; 25 mM HEPES-NaOH, pH 7.1; 0.75 mM Na 2 HPO 4 -NaH 2 PO 4 , pH 7.0; 125 mM NaCl) and plasmid DNA mix were added to the cells. Five hours after transfection, cells were shocked with PBS in 20% glycerol for 4 min, then washed with PBS twice. Fresh medium containing 5% fetal calf serum and 5 mM sodium butyrate was added to the cells. Cells were incubated at 37°C for 16 hr, then passaged at a 1:5 ratio onto a 24-well dish. These cells were treated with 25 µM FB 1 or 20 µM C 6 -ceramide (37°C for 48 hr), and β-gal expression was analyzed as described previously (27, 35) . Briefly, cells were rinsed with PBS, fixed with 2% formaldehyde, 0.2% glutaraldehyde in PBS for 5 min, then washed twice with PBS. Fixed cells were stained for 6-24 hr with 0.1% Bluo-gal (Gibco, Rockville, MD, USA) in a PBS solution containing 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2 mM MgCl 2 . After being rinsed in PBS, positive cells were observed microscopically and the number of stained blue cells counted. At least five fields per plate were counted, and the average number of cells per field was calculated.
Plasmids
pCMVCpIAP and pcDNA3/p35 are plasmids that contain baculovirus anti-apoptotic genes (36); these plasmids were obtained from L. Miller (University of Georgia, Athens, GA, USA). pcDNA/crmA (37) encodes a cowpox virus protein inhibitor of caspases and was obtained from L. Lou (University of Michigan Medical School, Ann Arbor, MI, USA). The adenovirus E1A or E1B 55-kDa encode proteins that bind Rb or p53, respectively, and were obtained from E. White (Rutgers University, Piscataway, NJ, USA). The expression vector that encodes Bcl-2 was obtained from J. Reed (La Jolla Cancer Research Center, La Jolla, CA, USA). CMV-β-gal was purchased from Clontech (Palo Alto, CA, USA). Human immunodeficiency virus (HIV) long terminal repeat (LTR) and HIV∆NFkB were obtained form C. Wood (University of Nebraska, Lincoln, NE, USA). Plasmid preparations were obtained by cesium chloride purification (38) .
Nuclear DNA Fragmentation Analysis
Cell cultures were treated with 5 µM FB 1 for 6, 12, 24, or 48 hr. Cells were then collected with a plastic cell scraper, suspended in TKMC buffer (10 mM Tris, pH 7.5; 10 mM KCl; 1 mM MgCl 2 ; 5 mM CaCl 2 ) containing 0.5% TX-100. Cells were lysed by treatment with 150 µg/mL of proteinase K, 100 mg RNAse A, and 0.1% sodium dodecyl sulfate (SDS). Genomic DNA was extracted with a phenol-chloroform-isoamyl alcohol solution (50:49:1). DNA samples were electrophoresed in a 1.5% agarose gel using TBE (0.1 M Tris, 0.1 M boric acid, 0.025 M EDTA, pH 8.3). DNA in the agarose gel was denatured with 1.5 M NaCl, 0.5 M NaOH for 30 min at room temperature, then neutralized by incubating with 3.0 M NaCl and 0.5 M Tris, pH 5.2, for 25 min. After the neutralization step was repeated, gels were rinsed in 2× SSC) (20 × SSC is 3 M NaCl and 0.3 M citric acid) and blotted onto a nylon membrane (Hy Bond+, Amersham). The DNA transferred to the membrane was hybridized with a monkey genomic DNA probe. The probe was radiolabeled by random priming method with 32 P by an enzymatic reaction catalyzed by the Klenow enzyme (New England Biolabs, Beverly, MA, USA). Prehybridization was performed at 65°C in 5× SSPE (0.75 M NaCl, 0.05 M sodium phosphate, 0.005 M EDTA), 0.5% bovine serum albumin, 0.5% polyvinylpyrrolidone and 1% SDS for 2 hr. Hybridization was carried out for 6-18 hr at 65°C by using 2 × 10 7 dpm of radiolabeled probe diluted in hybridization buffer. Filters were washed 3 times at room temperature and once at 65°C for 30 min in 1× SSPE, 1% SDS. Filters were then dried and exposed to film.
Measurement of Cyclin-Dependent Kinase Activity
Dishes were washed with PBS and cells were collected, and suspended in 500 µL of lysis buffer (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM EDTA; 10 mM dithiothreitol; 1 mM phenylmethylsulfonyl fluoride; 25% glycerol). Cell lysate was kept on ice for 20 min and lysed by two freeze/thaw cycles. Cells were centrifuged for 10 min at 12,000 rpm, and the supernatant was kept at -80°C. Immunoprecipitations were performed with 150 µg cell lysates for 3-4 hr at 4°C; 1 µg of antibody was used. Immunocomplexes were precipitated with protein A-Sepharose beads (Sigma, St. Louis, MO, USA) and washed 4 times with washing buffer (10 mM Tris-HCl, pH 8.0; 50 mM NaCl; 1 mM EDTA; 0.5% nonidet P40) (30) . Immunocomplexes were washed in 1× kinase buffer and the pellet was 
Analysis of Chloramphenicol Acetyltransferase Activity
CV-1 cells were transfected with the designated plasmids by calcium phosphate transfection as described previously (27, 34, 39) . Following transfection, cultures were treated with 5 µM FB 1 . Forty hours after transfection, cells were washed in PBS and a cell-free lysate was prepared by three freeze-thaw cycles in 0.25 M Tris (pH 7.8). Chlorophenicol acetyltranseferase (CAT) enzymatic activity was measured as described previously (39) . After thin-layer chromatography, the amount of 14 C-chloramphenicol (CM), acetylated or unacetylated, was measured with a PhosphorImager device.
Statistical Analysis
Statistical analyses were performed using Instat (Sigma Plot, Chicago, IL, USA), a personal computer software program. Results were considered statistically significant when the p value was < 0.05.
Results
Identification of Genes That Inhibit Fumonisin B 1 -Induced Apoptosis
By using a battery of well-accepted assays that identify apoptotic cells, several independent studies have concluded that FB 1 induces apoptosis in CV-1 cells (29) and human cells (26) (27) (28) (29) . To identify genes that regulate apoptosis, we used an assay based on cotransfecting cells with a β-gal expression plasmid (pCMV-β-gal) and a gene that regulates apoptosis (35, 40, 41) . If a gene induces apoptosis, the number of β-gal+ cells decrease. Conversely, anti-apoptotic genes increase the number of β-gal+ cells following induction of apoptosis, relative to controls. FB 1 consistently reduced the number of β-gal+ cells in CV-1 cells ( Figure 1A ). Reduction of β-gal+ cells correlated with apoptosis because nucleosome-length DNA and higher molecular weight forms of degraded DNA accumulated 24 or 48 hr after treatment ( Figure 1B , lanes 24 or 48). As expected, untreated CV-1 cells contained low levels of degraded DNA ( Figure 1B , lane C). In CV-1 cells, the baculovirus inhibitor of apoptosis (CpIAP) efficiently inhibited FB 1 -induced apoptosis (Figure 2 ). The Bcl-2 gene did not effectively inhibit apoptosis by FB 1 . Two caspase inhibitors, crmA and p35, appeared to give slightly different results. p35 consistently inhibited FB 1 -induced apoptosis slightly better than crmA in CV-1 cells. The adenovirus E1B gene encodes a 55-kDa protein that binds and inactivates the p53 tumor-suppressor protein [reviewed in (33) ]. E1B protected cells from apoptosis by FB 1 but not as efficiently as CpIAP. As expected, the adenovirus E1A gene induced apoptosis and FB 1 had little or no effect on this process. In summary, these studies indicated that CpIAP efficiently inhibited apoptosis by FB 1 .
FB 1 -Induced Apoptosis Does Not Require p53
To determine whether p53 was required for FB 1 -induced apoptosis, studies were performed in MEF derived from p53 -/-mice and subsequently compared to results obtained in p53 +/+ MEF. The studies presented in Figure 2 indicated that E1B did not completely prevent apoptosis by FB 1 , suggesting p53 was important but not required. We were particularly interested in determining whether p53 was required for FB 1 -induced apoptosis because of the importance p53 plays in apoptosis and cell growth. p53 -/ -cells are ideal for these studies because they are low-passage cells that lack only p53, whereas many established cells lacking p53 have additional unidentified mutations. Treatment of p53 -/-cells with 25 µM FB 1 for 24 hr led to the appearance of the typical DNA ladder characteristic of apoptosis ( Figure 3A) . When lower concentrations of FB 1 were used (5 µM), apoptosis occurred but at a lower efficiency (data not shown). The β-gal transfection assay also demonstrated that 25 µM FB 1 reduced the number of β-gal+ cells ( Figure 3B) , and CpIAP protected p53 -/-cells from apoptosis. p35 and CpIAP protected both MEF more efficiently from apoptosis relative to crmA. Bcl-2 protected p53 -/-MEF more effectively than p53 +/+ MEF from FB 1 -induced apoptosis. Although p53 was not absolutely required for apoptosis induced by FB 1 , it appeared to have an effect on the ability of Bcl-2 to inhibit apoptosis.
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Analysis of the TNF Pathway after FB 1 Treatment
CpIAP interferes with TNF/Fas induced apoptosis by binding to caspase 3, a direct target of caspase 8 and 9 [reviewed in (42) ; summarized in Figure 4 ]. This suggested the ability of CpIAP to efficiently inhibit FB 1 induced apoptosis was because the TNF signaling pathway was involved. However, CpIAP also binds directly to caspase 9 and 7, suggesting that FB 1 -induced apoptosis was not directly related to the TNF/Fas signaling pathway. Caspases are important for apoptosis because they degrade proteins necessary for cell survival. Because caspase 8 is required for TNF/Fasinduced apoptosis and it must be cleaved to be activated (43), we tested whether caspase 8 was cleaved after FB 1 treatment. An antibody that recognizes intact and cleaved caspase 8 was used for this study. At 2 and 6 hr after FB 1 treatment, a slight increase in the amount of cleaved caspase 8 (10-kDa band) was observed in CV-1 cells treated with 25 µM FB 1 ( Figure  5 ). Although similar levels of uncleaved caspase 8 were seen in control cultures, the amount of the 10-kDa band was lower. NF-κB activation can also occur following TNFR activation, but different accessory proteins are involved [(42); summarized in Figure  4 ]. In contrast to caspase 8 cleavage, activation of NF-κB appears to be related to cell survival (41) . Consequently, we tested whether FB 1 treatment had any effect on NF-κB activity. For this study, we used the HIVLTR and an NF-κB mutant (HIV∆NFκB). At 3, 24, or 48 hr after FB 1 treatment, neither plasmid had higher promoter activity ( Figure 6 ). In contrast, infection of cells transfected with HIV LTR with herpes simplex virus type 1 led to higher levels of HIV LTR promoter activity, as described previously (44) . Under identical conditions we previously demonstrated that the promoter regulating the cdk inhibitor (p21) was activated by FB 1 treatment (39). In summary, caspase 8 but not NF-κB was activated by FB 1 treatment.
Transient Activation of cdk2 by FB 1 Treatment
A previous study demonstrated that FB 1 treatment inhibited cdk2 activity in CV-1 cells (30) . This same study suggested that 3 hr after FB 1 treatment a slight increase in cdk2 activity occurred. This may be important because cdk activity increases during the early stages of apoptosis (32, 45) . To test whether FB 1 treatment increased cdk2 levels transiently, cdk2 activity was analyzed at different times during the early stages of treatment. Relative to control cultures, cdk2 activity increased at least 2-fold between 2 and 4 hr after treatment but then rapidly declined (Figure 7) . In contrast, cdk2 activity was not stimulated for 4-8 hr after CV-1 cells were plated in normal media. As expected, the amount of cdk2 activity continued to increase after serum treatment. In summary, this study demonstrated that cdk2 activity increased 2-to 3-fold at 2 and 4 hr after FB 1 treatment.
Discussion
In this study, the mechanism by which FB 1 induced apoptosis was examined in CV-1, p53 -/-MEF, and p53 +/+ MEF. Induction of apoptosis by FB 1 does not appear to require p53 because p53 -/-MEF undergo apoptosis following treatment (Figure 3) , and the E1B 55-kDa protein did not completely inhibit apoptosis (Figures 2, 3) . In p53 -/-cells, Bcl-2 protected cells from apoptosis more efficiently ( Figure 3B ), suggesting that under certain circumstances Bcl-2 can interfere with . FB 1 treatment has no effect on NF-κB transcriptional activity. CV-1 cells were transfected with the designated constructs. Following transfection, cells were treated with FB 1 (5 µM) such that the treatment lasted until 48 hr after transfection. CAT enzymatic activity was measured as described previously (39, 52) . The amount of acetylated chloramphenicol activity (Ac-CM) was quantified in a PhosphorImager. The results are representative of three independent experiments. (33) ]. Consequently, we hypothesized that the TNF/Fas pathway may be involved with FB 1 -induced apoptosis. The TNFR1 recruits caspase 8, resulting in proteolytic activation of caspase 8, which subsequently activates a caspase cascade (Figure 4) . The finding that caspase 8 was cleaved following FB 1 treatment ( Figure 5 ) supports the hypothesis that the TNF/Fas pathway was activated. CpIAP also associates with the signaling molecule TNFR-associated factor (TRAF) and functions as a component of the TNFR signaling complex (47) . TNF-α binds and activates TNFR, thus recruiting a TRAF-CpIAP complex to the cytoplasmic domain of TNFR. The TRAF-IAP complex consequently interferes with death signals activated by TNF. The recent finding that a TNFR-associated protein (TRAP)-2 is induced in CV-1 cells after FB 1 treatment lends support for the involvement of TNFR (48) . Because CpIAP can also bind to several caspases and inhibit their protease activity (42) , it is possible that inactivation of certain capsases by CpIAP inhibits FB 1 -induced apoptosis.
Although p35 and crmA are both caspase inhibitors, p35 inhibits a broader spectrum of caspases compared to crmA (49) . IAP family members physically interact with caspase 3, 7, and 9 [reviewed in (33, 42) ; Figure 4 ]. crmA has been reported to bind to caspase 8, but not caspase 9. crmA partially prevented apoptosis following FB 1 treatment, suggesting that the caspase 8 pathway is not the exclusive determinant in apoptosis. Our results cannot rule out the possibility that FB 1 treatment leads to activation of caspase 9, which is a proximal caspase in mitochondria-mediated apoptosis. Unlike caspase 8, we have not been able to demonstrate that caspase 9 was cleaved following FB 1 treatment (data not shown). Because caspase 9 activation requires interaction with active Apaf-1, but not proteolytic activation (50) , further experiments will be necessary to determine if the caspase 9 signaling pathway is also involved with FB 1 -induced apoptosis.
The association of TNFR with other factors, TNFR-associated death domain, TRAF2, Fas-associated death domain, or DAXX, can lead to apoptosis or NF-κB activation (41, 51) , which prevents cell death. The finding that FB 1 treatment did not lead to NF-κB ( Figure 6 ) or AP-1 activation (52) suggested that FB 1 treatment selectively activated components of the TNF pathway leading to cell death. When FB 1 is injected subcutaneously into mice (53), TNF-α activity increases. A TNF-α-like activity is also induced in swine after FB 1 injection (54). Induction of TRAP2 in CV-1 cells but not COS-7 cells (48) suggested that TRAP2 plays an important role in FB 1 -mediated apoptosis. Taken together, we hypothesize that induction of a TNF-like pathway in FB 1 -treated cells has relevance to its toxic and carcinogenic properties. Future experiments will focus on identifying the factors in the TNF pathway that are induced by FB 1 . Figure 7 . Measurement of cdk2 activity in CV-1 and COS-7 cells after FB 1 treatment. Total cell lysate was prepared from untreated or FB 1 -treated CV-1 and COS-7 cells (5 µM of FB 1 for 3, 24, and 48 hr). Cdk2/cyclin complexes were immunoprecipitated with specific antibodies directed against the Cdk2 (Santa Cruz Biotech, Santa Cruz, CA, USA). Immunocomplexes were collected by incubation with protein A-Sepharose beads. glutathione S-transferase-Rb was used as a substrate to measure Cdk2 activity present in immunocomplexes as described previously (30) . Following incubation with 32 P-γ-ATP, the proteins were electrophoresed on 10% SDS-PAGE, and the dried gel was autoradiographed. The results shown are the mean of four independent experiments. 
